Task: Answer the multiple-choice question.
Question: Which drug exhibits a 0.793% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) CC(=O)N1CCN(c2ccc(NC(=O)COc3ccc(Cl)cc3Cl)cc2)CC1
b) CCNc1ccccc1C(=O)O
c) CCCC(NC(=O)C(C)Sc1nnnn1C1CC1)c1ccccc1
d) COc1ccc(C(=O)Nc2ccccc2N2CCN(C(=O)c3ccccc3)CC2)cc1Br
Answer: c. CCCC(NC(=O)C(C)Sc1nnnn1C1CC1)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCC(NC(=O)C(C)Sc1nnnn1C1CC1)c1ccccc1
CCCC(NC(=O)C(C)Sc1nnnn1C1CC1)c1ccccc1
2-(1-cyclopropyltetrazol-5-yl)sulfanyl-N-(1-phenylbutyl)propanamide